China tensions, following US restrictions on Chinese rivals BGI and MGI. Illumina says China accounts for 7% of Q3 revenue.

The field of plant biotechnology is undergoing a profound transformation. The rise of generative artificial intelligence (AI) ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Fintel reports that on February 3, 2025, HC Wainwright & Co. initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...

By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

Encasing CRISPR tools in oil droplets offers a fast-track approach to conducting extensive genetic screens in animals.

Cutting-edge editing techniques are accelerating efforts to create high-yield, resilient varieties of major agricultural products.

What makes the perfect human? Immaculate features? Indomitable Intelligence? Incomparable wit? Or irresistible charm? What if ...

Overnight DeepSeek is the role model of the startup ecosystem. It is demonstrating real-time to every business, idea, or ...

KBC Group NV lifted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2,047.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and ...